These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22045472)

  • 1. VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer.
    Biselli-Chicote PM; Oliveira AR; Pavarino EC; Goloni-Bertollo EM
    J Cancer Res Clin Oncol; 2012 Mar; 138(3):363-70. PubMed ID: 22045472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo.
    Merdzhanova G; Gout S; Keramidas M; Edmond V; Coll JL; Brambilla C; Brambilla E; Gazzeri S; Eymin B
    Oncogene; 2010 Sep; 29(39):5392-403. PubMed ID: 20639906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-A splicing: the key to anti-angiogenic therapeutics?
    Harper SJ; Bates DO
    Nat Rev Cancer; 2008 Nov; 8(11):880-7. PubMed ID: 18923433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis.
    Nowak DG; Amin EM; Rennel ES; Hoareau-Aveilla C; Gammons M; Damodoran G; Hagiwara M; Harper SJ; Woolard J; Ladomery MR; Bates DO
    J Biol Chem; 2010 Feb; 285(8):5532-40. PubMed ID: 19906640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.
    Nowak DG; Woolard J; Amin EM; Konopatskaya O; Saleem MA; Churchill AJ; Ladomery MR; Harper SJ; Bates DO
    J Cell Sci; 2008 Oct; 121(Pt 20):3487-95. PubMed ID: 18843117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance.
    Hamdollah Zadeh MA; Amin EM; Hoareau-Aveilla C; Domingo E; Symonds KE; Ye X; Heesom KJ; Salmon A; D'Silva O; Betteridge KB; Williams AC; Kerr DJ; Salmon AH; Oltean S; Midgley RS; Ladomery MR; Harper SJ; Varey AH; Bates DO
    Mol Oncol; 2015 Jan; 9(1):167-78. PubMed ID: 25224594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma.
    Pritchard-Jones RO; Dunn DB; Qiu Y; Varey AH; Orlando A; Rigby H; Harper SJ; Bates DO
    Br J Cancer; 2007 Jul; 97(2):223-30. PubMed ID: 17595666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth.
    Peiris-Pagès M; Harper SJ; Bates DO; Ramani P
    J Pathol; 2010 Oct; 222(2):138-47. PubMed ID: 20662003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-angiogenic isoforms of VEGF in health and disease.
    Qiu Y; Hoareau-Aveilla C; Oltean S; Harper SJ; Bates DO
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1207-13. PubMed ID: 19909248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of VEGF 165b in pathophysiology.
    Peiris-Pagès M
    Cell Adh Migr; 2012; 6(6):561-8. PubMed ID: 23076130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.
    Rennel E; Waine E; Guan H; Schüler Y; Leenders W; Woolard J; Sugiono M; Gillatt D; Kleinerman E; Bates D; Harper S
    Br J Cancer; 2008 Apr; 98(7):1250-7. PubMed ID: 18349828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.
    Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N
    Cells; 2019 Jan; 8(1):. PubMed ID: 30641926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alternative splicing of vascular endothelial growth factor A and ocular neovascularization].
    Fan SJ; He SZ
    Zhonghua Yan Ke Za Zhi; 2011 Apr; 47(4):373-7. PubMed ID: 21612688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue stiffness regulates serine/arginine-rich protein-mediated splicing of the extra domain B-fibronectin isoform in tumors.
    Bordeleau F; Califano JP; Negrón Abril YL; Mason BN; LaValley DJ; Shin SJ; Weiss RS; Reinhart-King CA
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8314-9. PubMed ID: 26106154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis.
    Shibuya M
    BMB Rep; 2008 Apr; 41(4):278-86. PubMed ID: 18452647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in tumor angiogenesis.
    Wang W; Zhang E; Lin C
    Life Sci; 2015 Sep; 136():28-35. PubMed ID: 26144623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm.
    Ladomery MR; Harper SJ; Bates DO
    Cancer Lett; 2007 May; 249(2):133-42. PubMed ID: 17027147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing.
    Guyot M; Pagès G
    Methods Mol Biol; 2015; 1332():3-23. PubMed ID: 26285742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.